Frank d'amelio net worth

Frank D’Amelio is the former Executive Vice President & Chief Financial Officer at Pfizer Inc, responsible for all corporate finance functions including audit, treasury, tax, investor relations, insurance, operations planning and analysis, corporate controllership, and business finance and analytics.  From 2019 through 2021, Frank was the Chief Financial Officer & Executive Vice President, Global Supply responsible for Pfizer’s worldwide global supply chain.  This included the manufacture and distribution of the COVID vaccine. More than 3B doses of the COVID vaccine were made in the first year of production.

At Pfizer, Frank has led the acquisition and integration of Wyeth Pharmaceuticals, King Pharmaceuticals, Hospira Inc., Anacor Pharmaceuticals, Inc., Medivation, Inc. and Array, as well as the spin-off of Pfizer’s animal health business, Zoetis, the sale of its nutrition business to Nestle and its Capsugel business to KKR, the formation of the Consumer JV with GSK and the formation of Viatris with Mylan.

During Frank’s tenure as the P

•